EFFECTS OF TACROLIMUS-ELUTING STENTS IN A DIABETIC RABBIT MODEL OF IN-STENT RESTENOSIS

被引：0
|
作者：
Radke, P. W. [1 ]
Joost, A. [1 ]
Kaiser, A. [2 ]
Mandapathil, M. [2 ]
Basler, M. [2 ]
Yla-Herttuala, S. [3 ]
Weber, C. [2 ]
Ito, W. [1 ]
机构：
[1] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany
[2] Rhein Westfal TH Aachen, Aachen, Germany
[3] Univ Kuopio, FIN-70211 Kuopio, Finland
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2011年 / 12卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(11)70378-6
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
377
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [31] REPLY: Paclitaxel-Eluting Balloons or Everolimus-Eluting Stents for In-Stent Restenosis
    Claessen, Bimmer E. P. M.
    Baan, Jan, Jr.
    Henriques, Jose P. S.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (05) : 506 - 507
  • [32] Treatment of in-stent restenosis in drug eluting stents: Have stent sandwiches solved the problem?
    Shelton, M
    Moore, A
    Shelton, MC
    Ligon, R
    Mishkel, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 44B - 44B
  • [33] Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stents
    Kim, Jung-Sun
    Lee, Seung-Yul
    Lee, Jung Myung
    Yoon, Young Won
    Ahn, Chul-Min
    Kim, Myung-Hyun
    Min, Pil-Ki
    Ko, Young-Guk
    Hong, Bum-Kee
    Choi, Donghoon
    Kwon, Hyuck Moon
    Jang, Yangsoo
    Shim, Won-Heum
    CORONARY ARTERY DISEASE, 2009, 20 (01) : 59 - 63
  • [34] A New Application for Urethral Strictures: Tacrolimus-Eluting Stent
    Karatas, Omer Faruk
    Cimentepe, Ersin
    Bayrak, Omer
    Unal, Dogan
    JOURNAL OF ENDOUROLOGY, 2010, 24 (06) : 1043 - 1044
  • [35] Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis The Treatment of In-Stent Restenosis Study
    Pleva, Leos
    Kukla, Pavel
    Kusnierova, Pavlina
    Zapletalova, Jana
    Hlinomaz, Ota
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (04)
  • [36] Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis
    Goel, Sachin
    El-Mallah, Wael
    Ige, Mobolaji
    Gupta, Supriya
    Tuzcu, E. Murat
    Ellis, Stephen
    Kapadia, Samir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B194 - B194
  • [37] Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis
    Lim, Sang Yup
    Jeong, Myung Ho
    Hong, Soon Jun
    Lim, Do Sun
    Moon, Jae Youn
    Hong, Young Joon
    Kim, Ju Han
    Ahn, Youngkeun
    Kang, Jung Chaee
    CIRCULATION JOURNAL, 2008, 72 (03) : 463 - 468
  • [38] The porcine coronary model of in-stent restenosis: Current status in the era of drug-eluting stents
    Lowe, HC
    Schwartz, RS
    Mac Neill, BD
    Jang, LK
    Hayase, M
    Rogers, C
    Oesterle, SN
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2003, 60 (04) : 515 - 523
  • [39] Angiographic patterns of in-stent restenosis are different between sirolimus-eluting stents and paclitaxel-eluting stents
    Hong, SJ
    Kim, MH
    Ahn, TH
    Bae, JH
    Ahn, YK
    Shim, WJ
    Ro, YM
    Lim, DS
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 168H - 169H
  • [40] Angiographic patterns of in-stent restenosis are different between sirolimus-eluting stents and paclitaxel-eluting Stents
    Hong, SJ
    Kim, MH
    Ahn, TH
    Bae, JH
    Ahn, YK
    Park, MY
    Shin, SH
    Shim, W
    Ro, YM
    Lim, DS
    CIRCULATION, 2005, 112 (17) : U537 - U537
12345